Adaptive and dose redistributed radiotherapy in head and neck cancer: ARTFORCE RCT phase III results

Category Primary study
JournalRadiotherapy and oncology
Year 2023
This article has no abstract
Epistemonikos ID: f2d7cdc0d581b4d134c1c6f88d8a5fab7503d77d
First added on: Dec 07, 2023